These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31606743)

  • 21. Using Ustekinumab to Treat Crohn's Disease-Related Orofacial Granulomatosis: Two Birds, One Stone.
    Gilmore R; Li Wai Suen CFD; Elliott T; De Cruz P; Srinivasan A
    Inflamm Bowel Dis; 2020 Jul; 26(8):e79-e80. PubMed ID: 32448910
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of Ustekinumab on Extraintestinal Diseases in Refractory Crohn's Disease.
    Tursi A; Mocci G; Maconi G
    J Crohns Colitis; 2021 Aug; 15(8):1399-1400. PubMed ID: 33580249
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful pregnancy outcome under prolonged ustekinumab treatment in a patient with Crohn's disease and paradoxical psoriasis.
    Galli-Novak E; Mook SC; Büning J; Schmidt E; Zillikens D; Thaci D; Ludwig RJ
    J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):e191-e192. PubMed ID: 26559393
    [No Abstract]   [Full Text] [Related]  

  • 24. Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient.
    Martínez-Montiel M; Piedracoba-Cadahia P; Gómez-Gómez C; Gonzalo J
    J Crohns Colitis; 2015 Sep; 9(9):816-7. PubMed ID: 26071409
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis.
    Pepple KL; Lin P
    Ophthalmology; 2018 Dec; 125(12):1977-1983. PubMed ID: 30458922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Case Where Administration of Ustekinumab Maintained the Intestinal Patency After Balloon Dilation for Small Intestinal Stenosis Caused by Crohn's Disease.
    Murate K; Nakamura M; Fujishiro M
    Inflamm Bowel Dis; 2019 Oct; 25(11):e140. PubMed ID: 31374114
    [No Abstract]   [Full Text] [Related]  

  • 27. Ustekinumab: a novel therapeutic option in Crohn's disease.
    Simon EG; Samuel S; Ghosh S; Moran GW
    Expert Opin Biol Ther; 2016 Aug; 16(8):1065-74. PubMed ID: 27341173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positioning biologics-A case-based discussion: Ustekinumab.
    Begun J
    J Gastroenterol Hepatol; 2018 Sep; 33 Suppl 3():16-17. PubMed ID: 30187551
    [No Abstract]   [Full Text] [Related]  

  • 29. Elderly-onset Crohn's disease remarkably responsive to ustekinumab: a case report.
    Iwamoto M; Kato K; Moriyama M
    Int J Colorectal Dis; 2020 Feb; 35(2):355-359. PubMed ID: 31848740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Rituximab-induced Crohn's Disease With Ustekinumab Induction and Long-term Maintenance of Remission.
    Shankar U; Vijayasekar K; Bansal R; Walfish A
    Inflamm Bowel Dis; 2020 Jan; 26(1):e3. PubMed ID: 31693734
    [No Abstract]   [Full Text] [Related]  

  • 31. Ustekinumab and remission in perianal Crohn's disease: A case report.
    Alcántara-Figueroa CE; Coronado-Rivera EF; Estela-Vásquez EF; Calderón-Cabrera DC; Alcántara-Ascón RA
    Rev Gastroenterol Mex (Engl Ed); 2023; 88(4):431-432. PubMed ID: 37270408
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab.
    Low ZM; Mar A
    Australas J Dermatol; 2018 May; 59(2):131-134. PubMed ID: 29205260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-TNFalpha therapy in a rare case of Crohn's disease: still a panacea.
    Verburg R; Zelissen P; Rothova A; Siersema PD; Oldenburg B
    Inflamm Bowel Dis; 2008 Oct; 14(10):1457-60. PubMed ID: 18383178
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful treatment of ustekinumab in a psoriasis patient with human T-cell leukemia/lymphotropic virus type 1 infection.
    Kazama M; Umezawa Y; Itoh M; Nobeyama Y; Ito T; Kikuchi S; Yanaba K; Asahina A; Nakagawa H; Ogasawara Y
    J Dermatol; 2017 Nov; 44(11):1334-1335. PubMed ID: 27864824
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful Treatment of Oral Crohn's Disease by Ustekinumab.
    Jukema JB; Brandse JF; de Boer NKH
    Inflamm Bowel Dis; 2020 Feb; 26(3):e19. PubMed ID: 31907551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ustekinumab to treat Crohn's disease.
    Gisbert JP; Chaparro M
    Gastroenterol Hepatol; 2017 Dec; 40(10):688-698. PubMed ID: 29042094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Amyloidosis, thromboembolic complications, and uveitis in Crohn's disease].
    Garrido Sanjuán JA; Castro Alvariño J; Peromingo JA; Míguez DD
    Rev Clin Esp; 1993 Nov; 193(8):458-9. PubMed ID: 8115704
    [No Abstract]   [Full Text] [Related]  

  • 38.
    Borrás-Blasco J; Cortes X; Fernandez-Martinez S; Casterá E; Antequera B
    Am J Health Syst Pharm; 2017 Feb; 74(4):209-212. PubMed ID: 28179246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection.
    Saeki H; Ito T; Hayashi M; Fukuchi O; Umezawa Y; Nobeyama Y; Teruya K; Nakagawa H
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1653-5. PubMed ID: 24754476
    [No Abstract]   [Full Text] [Related]  

  • 40. Ustekinumab for hidradenitis suppurativa: a case report.
    Santos-Pérez MI; García-Rodicio S; Del Olmo-Revuelto MA; Pozo-Román T
    Actas Dermosifiliogr; 2014 Sep; 105(7):720-2. PubMed ID: 24308927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.